What are the benefits and harms of fixed-dose combination therapy for primary or secondary prevention of atherosclerotic cardiovascular disease?

Cochrane Clinical Answers ◽

10.1002/cca.1897 ◽

2018 ◽

Keyword(s):

Cardiovascular Disease ◽

Combination Therapy ◽

Secondary Prevention ◽

Fixed Dose Combination ◽

Fixed Dose ◽

Atherosclerotic Cardiovascular Disease ◽

Dose Combination

Download Full-text

Fixed-dose combination therapy for the prevention of cardiovascular disease

10.1002/14651858.cd009868 ◽

2012 ◽

Author(s):

Angharad N de Cates ◽

Matthew RB Farr ◽

Karen Rees ◽

Juan P Casas ◽

Mark Huffman

Keyword(s):

Cardiovascular Disease ◽

Combination Therapy ◽

Fixed Dose Combination ◽

Fixed Dose ◽

Dose Combination ◽

Prevention Of Cardiovascular Disease

Download Full-text

Fixed-dose combination therapy to reduce the growing burden of cardiovascular disease in low- and middle-income countries: feasibility and challenges

Journal of Clinical Hypertension ◽

10.1111/jch.13162 ◽

2018 ◽

Vol 20 (1) ◽

pp. 168-173 ◽

Cited By ~ 3

Author(s):

Jobert Richie Nansseu ◽

Aurel T. Tankeu ◽

Joseph Kamtchum-Tatuene ◽

Jean Jacques Noubiap

Keyword(s):

Cardiovascular Disease ◽

Combination Therapy ◽

Fixed Dose Combination ◽

Fixed Dose ◽

Middle Income ◽

Middle Income Countries ◽

Dose Combination ◽

Low And Middle Income

Download Full-text

Fixed dose combination therapy for secondary prevention of major cardiovascular events: review of literature and design for Persian Polypill, a randomized clinical trial

Current Problems in Cardiology ◽

10.1016/j.cpcardiol.2021.100872 ◽

2021 ◽

pp. 100872

Author(s):

Masoumeh Sadeghi ◽

Shervin Ghaffari Hoseini ◽

Alireza Nateghi ◽

Nizal Sarrafzadegan ◽

Marjan Mansoorian ◽

...

Keyword(s):

Clinical Trial ◽

Combination Therapy ◽

Secondary Prevention ◽

Randomized Clinical Trial ◽

Cardiovascular Events ◽

Fixed Dose Combination ◽

Fixed Dose ◽

Review Of Literature ◽

Major Cardiovascular Events ◽

Dose Combination

Download Full-text

Cost-effectiveness of a fixed-dose combination pill for secondary prevention of cardiovascular disease in China, India, Mexico, Nigeria, and South Africa: a modelling study

The Lancet Global Health ◽

10.1016/s2214-109x(19)30339-0 ◽

2019 ◽

Vol 7 (10) ◽

pp. e1346-e1358 ◽

Cited By ~ 5

Author(s):

John K Lin ◽

Andrew E Moran ◽

Kirsten Bibbins-Domingo ◽

Bode Falase ◽

Andrea Pedroza Tobias ◽

...

Keyword(s):

South Africa ◽

Cardiovascular Disease ◽

Cost Effectiveness ◽

Secondary Prevention ◽

Fixed Dose Combination ◽

Fixed Dose ◽

Dose Combination ◽

Combination Pill ◽

Prevention Of Cardiovascular Disease ◽

Modelling Study

Download Full-text

PCV53 COST-EFFECTIVENESS OF THE CNIC POLYPILL - FIXED DOSE COMBINATION OF ACETYLSALICYLIC ACID, RAMIPRIL AND ATORVASTATIN - FOR THE SECONDARY PREVENTION OF CARDIOVASCULAR DISEASE IN GREECE

Value in Health ◽

10.1016/j.jval.2019.09.778 ◽

2019 ◽

Vol 22 ◽

pp. S550

Author(s):

G. Ntaios ◽

K. Vemmos ◽

P. Papapetrou ◽

S. Zafeiri ◽

G. Rubio

Keyword(s):

Cardiovascular Disease ◽

Cost Effectiveness ◽

Secondary Prevention ◽

Acetylsalicylic Acid ◽

Fixed Dose Combination ◽

Fixed Dose ◽

Dose Combination ◽

Prevention Of Cardiovascular Disease

Download Full-text

Fixed-Dose Combination Therapy (Polypill) for the Prevention of Cardiovascular Disease

JAMA ◽

10.1001/jama.2014.13616 ◽

2014 ◽

Vol 312 (19) ◽

pp. 2030 ◽

Cited By ~ 7

Author(s):

Mark D. Huffman ◽

Angharad N. de Cates ◽

Shah Ebrahim

Keyword(s):

Cardiovascular Disease ◽

Combination Therapy ◽

Fixed Dose Combination ◽

Fixed Dose ◽

Dose Combination ◽

Prevention Of Cardiovascular Disease

Download Full-text

Fixed-dose combination therapy for the prevention of cardiovascular disease

10.1002/14651858.cd009868.pub2 ◽

2014 ◽

Cited By ~ 21

Author(s):

Angharad N de Cates ◽

Matthew RB Farr ◽

Nicola Wright ◽

Morag C Jarvis ◽

Karen Rees ◽

...

Keyword(s):

Cardiovascular Disease ◽

Combination Therapy ◽

Fixed Dose Combination ◽

Fixed Dose ◽

Dose Combination ◽

Prevention Of Cardiovascular Disease

Download Full-text

Efficacy of Olmesartan Medoxomil and Hydrochlorothiazide Fixed-Dose Combination Therapy in Patients Aged 65 Years and Older with Stage 1 and 2 Hypertension or Isolated Systolic Hypertension

American Journal of Cardiovascular Drugs ◽

10.2165/11635000-000000000-00000 ◽

2012 ◽

Vol 12 (5) ◽

pp. 325-333 ◽

Cited By ~ 1

Author(s):

F. Wilford Germino ◽

Joel M. Neutel ◽

Robert Dubiel ◽

Jen-Fue Maa ◽

Kathleen J. Chavanu

Keyword(s):

Combination Therapy ◽

Systolic Hypertension ◽

Olmesartan Medoxomil ◽

Fixed Dose Combination ◽

Fixed Dose ◽

Isolated Systolic Hypertension ◽

Dose Combination ◽

Stage 1

Download Full-text

Single-Pill Triple Fixed Dose Combination Therapy with Single Component Drug Monitoring in Treatment-Resistant Hypertension: A Pilot Study

Current Vascular Pharmacology ◽

10.2174/1570161115666170821155555 ◽

2018 ◽

Vol 16 (2) ◽

pp. 197-203 ◽

Cited By ~ 1

Author(s):

Reinhold Kreutz ◽

Jurgen Scholze ◽

Antonios Douros

Keyword(s):

Pilot Study ◽

Combination Therapy ◽

Drug Monitoring ◽

Resistant Hypertension ◽

Single Component ◽

Fixed Dose Combination ◽

Fixed Dose ◽

Treatment Resistant ◽

Single Pill ◽

Dose Combination

Download Full-text

Treatment of Open-Angle Glaucoma and Ocular Hypertension with Preservative-Free Tafluprost/Timolol Fixed-Dose Combination Therapy: UK and Ireland Results from the VISIONARY Study

Advances in Therapy ◽

10.1007/s12325-021-01725-7 ◽

2021 ◽

Author(s):

Ejaz Ansari ◽

◽

Jasna Pavicic-Astalos ◽

Filis Ayan ◽

Anthony J. King ◽

...

Keyword(s):

Combination Therapy ◽

Ocular Hypertension ◽

Open Angle Glaucoma ◽

Fixed Dose Combination ◽

Fixed Dose ◽

Open Angle ◽

Dose Combination ◽

Preservative Free

Download Full-text